ReproBone fusion
Commercial- Indications
- Bone repair, Spinal fusion
Company intelligence / Profile preview
Ceramisys manufactures and markets ReproBone®, a synthetic bone graft substitute with a composition similar to human cancellous bone. The product is used globally in orthopaedic, spinal, and dental surgeries as an alternative or supplement to autograft/allograft. Clinical case studies and pre-clinical data support its efficacy for stimulating new bone growth and reducing donor site morbidity. The company’s products are approved in most international markets.
3 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ceramisys.